All articles tagged: Acute bronchiolitis due to respiratory syncytial virus (J21.0)
HealthDay
27 June at 11.32 AM
CDC Strengthens RSV Vaccine Advice for Those Over 75In new vaccination guidance issued Wednesday, U.S. health officials now recommend that all Americans aged 75 and older get an RSV vaccine before fall arrives.However, those a bit younger -- ages 60 to 74 -- should only seek the shot if they are vulnerable to severe RSV because of chronic medical conditions such as lung or heart disease, or if |
Evalytics
22 January at 03.28 PM
Wastewater tests can find mpox, study finds. Expect more bugs to be tracked that wayWastewater testing is effective in detecting infections like mpox, with a 32% likelihood of detection. It's a valuable tool for early disease detection and monitoring, including COVID-19, and will expand to track antibiotic-resistant germs and food poisoning bugs. |
HealthDay
16 January at 11.49 PM
CDC: Although Season Not Over, Flu Activity Is Slowing DownFor the first time in months, there has been "a single-week decrease" in flu activity, according to data released by the U.S. Centers for Disease Control and Prevention.But health officials warn that the flu season is far from over, with a surge expected shortly. "Folks try not to seek care |
Evalytics
05 January at 08.44 PM
Respiratory virus activity is high or increasing in most parts of the US and it still hasn’t peakedCDC warns of rising respiratory virus cases in the US, driven by increased COVID-19 hospitalizations, especially among children, and a surge in flu and RSV cases. Low vaccination rates remain a concern. |
HealthDay
28 December at 11.36 PM
Nearly Half of U.S. COVID-19 Cases Now Caused by JN.1 VariantThe JN.1 variant, a descendant of the variant BA.2.86, now accounts for 44 percent of COVID-19 cases, up from roughly 7 percent in late November, the latest data from the U.S. Centers for Disease Control and Prevention show.The speed at which the JN.1 variant has sprea |
HealthDay
28 December at 04.55 PM
Nirsevimab Protects Infants Against RSV-Linked HospitalizationNirsevimab is efficacious for preventing hospitalization for respiratory syncytial virus (RSV)-associated lower respiratory tract infection among infants, according to a study published in the Dec. 28 issue of the New England Journal of Medicine.Simon B. Drysdale, Ph.D., from the Centre for Neonatal and Paediatric Infections at the Un |
HealthDay
21 December at 11.21 PM
Many U.S. Nursing Home Residents Have Not Been Vaccinated for Flu, COVID-19, or RSV for 2023-24Many nursing home residents and adults have not been vaccinated for influenza, COVID-19, or respiratory syncytial virus (RSV) for the 2023 to 2024 season, according to research published in the Dec. 22 issue of the U.S. Centers for Disease Control and Prevention Morbidity and Mortality Weekly Report.Hannah E. Reses, M.P.H., from the C |
HealthDay
14 December at 05.00 PM
Single Dose of mRNA-1345 Vaccine Safe, Effective Against RSV in SeniorsA single dose of mRNA-1345 vaccine is safe and results in lower incidence of respiratory syncytial virus (RSV)-associated disease in older patients, according to a study published in the Dec. 14 issue of the New England Journal of Medicine.Eleanor Wilson, M.D., from Moderna in Cambridge, Massachusetts, and colleagues conducted a rando |
Evalytics
27 November at 06.14 PM
WHO asks China for more information on spike in pediatric respiratory illnessesThe World Health Organization (WHO) is seeking more information from China about a rise in respiratory illnesses and pneumonia in children, following the lifting of COVID-19 restrictions. This increase is linked to various pathogens, including influenza and RSV. There are also reports of undiagnosed pediatric pneumonia cases in northern China. The WHO has requested detailed data from China and adv |
HealthDay
30 October at 09.26 PM
Transient Decrease in Pediatric Bronchiolitis Hospitalizations Seen During PandemicDuring the COVID-19 pandemic era, pediatric bronchiolitis hospitalizations decreased transiently, then increased, according to a study published online Oct. 26 in JAMA Network Open.Kailey A. Remien, D.O., from Akron Children's Hospital in Ohio, and colleagues conducted a retrospective cross-sectional study using data from 41 U.S. childr |
HealthDay
30 October at 09.22 PM
Infectious Diseases Society of America, Oct. 11-15The annual meeting of the Infectious Diseases Society of America was held this year from Oct. 11 to 15 in Boston and attracted participants from around the world, including scientists, physicians, and other health care professionals. The conference featured education courses and comprehensive educational programs that focused on the latest advances in the d |
Medical xPress
05 July at 07.10 AM
When it comes to male life expectancy, nature and nurture work togetherAlthough the simple biological fact (nature) of being born male increases boys' and men's overall health risks, the behavioral choices (nurture) they make are at least as important. This means that trans men and others who identify as men, while not biologically male, may also experience the behavioral disadvantages of being male. |
Medical xPress
05 July at 06.50 AM
Study explores the link between stock market fluctuations and emergency room visits in ChinaThe advent of computerized trading and fintech platforms has made investing in stocks easier and more accessible to individuals worldwide. This has led to an increase in stock market participation in many countries, including China. |
Medical xPress
30 June at 07.40 AM
Decision to offer sedation for often-painful IUD insertion is 'groundbreaking,' health experts sayIntrauterine devices (IUDs) are a highly effective and long-lasting form of birth control placed in the uterus. Research shows that many people who get IUDs experience moderate to intense pain during the insertion. But it wasn't until recently that providers began to acknowledge this and do something about it. |
HealthDay
27 June at 03.19 PM
Immunoglobulin Replacement Therapy Beneficial for Blood CancersImmunoglobulin replacement therapy (IgRT) is associated with reductions in hypogammaglobulinemia, infections, severe infections, and associated antimicrobial use among real-world patients with chronic lymphocytic leukemia (CLL) or non-Hodgkin lymphoma (NHL), according to a study published online June 21 in Blood Advances.Jacob D. Soum |
Medpage Today
26 June at 04.59 PM
When Was the Last Time You Really Talked With Your Patient?My 10 o'clock patient's name is Maria*. Her chart has three "health maintenance" flags that are bright red, indicating that she is more than 3 years overdue for a mammogram, more than 6 years overdue for a Pap smear, and has... |
Medpage Today
23 June at 09.21 PM
Novel Triple-Hormone Agonist Boosts Beta-Cell Function in T2DORLANDO -- An investigational triple-hormone receptor agonist improved metabolic profiles of people with obesity with or without type 2 diabetes, an exploratory biomarker analysis of a phase II trial found. After 36 weeks... |
Medpage Today
22 June at 06.00 PM
Fenofibrate Slows Diabetic Retinopathy ProgressionORLANDO -- The cholesterol drug fenofibrate reduced progression of early eye disease among diabetes patients, the LENS trial showed. The fibrate reduced progression of early diabetic retinopathy or maculopathy by a relative... |
Medpage Today
22 June at 06.00 PM
Preventing Surgical-Site Infections; Drugs Go Head to Head for Ischemic StrokeTTHealthWatch is a weekly podcast from Texas Tech. In it, Elizabeth Tracey, director of electronic media for Johns Hopkins Medicine in Baltimore, and Rick Lange, MD, president of the Texas Tech University Health Sciences Center... |
Medical xPress
22 June at 05.20 PM
Lawsuit could challenge trust in Ozempic and other popular weight loss drugsThe manufacturers of the most popular weight loss drugs are being challenged in court. |
HealthDay
21 June at 03.38 PM
Overall Prevalence of Being Up-to-Date With Lung Cancer Screening Is LowThe overall prevalence of up-to-date (UTD) lung cancer screening (LCS) was low in 2022, with prevalence increasing with age and number of comorbidities, according to a study published online June 10 in JAMA Internal Medicine.Priti Bandi, Ph.D., from the American Cancer Society in Atlanta, and colleagues estimated the contemporary preval |